ConductScience.org, home

Paper1361883

Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice.

Stanley LA and 6 others. Carcinogenesis, 1992. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Papers, record 1361883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1361883

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice.
PubMed
Journal
Carcinogenesis
PubMed
Year
1992
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2019-05-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stanley LAL A
2Devereux TRT R
3Foley JJ
4Lord PGP G
5Maronpot RRR R
6Orton TCT C
7Anderson MWM W

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genes, rasMajor topic
Liver Neoplasms, ExperimentalMajor topic
3T3 Cells
Animals
Base Sequence
Blotting, Southern
Codon
DNA, Neoplasm
Disease Susceptibility
Gene Expression
Male
Mice
Mice, Inbred C57BL
Mice, Nude
Molecular Sequence Data
Point Mutation
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Transfection

Source PubMed

Download CSV of topics

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
38127128Physiologically-based pharmacokinetic model for evaluating gender-specific exposures of N-nitrosodimethylamine (NDMA).Arch Toxicol2024https://conductscience.org/library/papers/38127128PubMed
20962274Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20962274PubMed
16012954Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.Gastroenterology2005https://conductscience.org/library/papers/16012954PubMed
9539005Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.Environ Health Perspect1998https://conductscience.org/library/papers/9539005PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1361883

GET https://conductscience.org/api/papers/v1/1361883/authors